Company intelligence
Amai Proteins
Biotechnology Research
Rehovot, IL
50 employees
Founded 2016
3 public signals
About Amai Proteins
Amai develops novel proteins that answer the needs of consumers and industry. The first application is sweet protein, inspired by nature, and built with biology through a natural fermentation process. With its pro-protein platform, the company creates new breakthroughs which are set to shape the future of proteins.
Verified activity
Signals from Amai Proteins
3 published signals
People
Amai Proteins appointed Doug Brown as new CEO effective September 1, 2026.
Reported by Amai Proteins
Research & Knowledge
Amai Proteins published human clinical data showing sweelin did not increase blood glucose, insulin, or GLP-1 levels in healthy adults.
Reported by Rena Cohen-First
Legal & Regulatory
Amai Proteins received regulatory approval from the Israeli Ministry of Health to use sweelin as a novel food ingredient across more than 25 food and beverage categories.
Reported by Amai Proteins